Pfizer makes $3.6B deal to buy King Pharmaceuticals (Morning Read)
Its $3.6 billion deal to buy King Pharmaceuticals will be Pfizer's largest since it bought rival Wyeth for $68 billion in 2009. That acquisition included Wyeth's vaccine plant in Sanford, North Carolina, where Pfizer plans to cut 400 workers over the next five years, according to the News & Observer.